NCT00557284View on ClinicalTrials.gov

Efficacy Study of Montelukast in Atopic Dermatitis Induced by Food Allergens

PHASE4CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

March 31, 2008

Primary Completion Date

May 31, 2009

Study Completion Date

May 31, 2009

Conditions
Atopic Dermatitis
Interventions
DRUG

Montelukast

4 mg oral granules for ages 12 - 23 months; 4 mg chewable tablet for 2 - 5 years of age; or 5 mg chewable tablet for 6 - 8 years of of age

DRUG

Placebo

Oral granules or chewable tablet, PO QD (given oral daily)

Trial Locations (2)

80112

1st Allergy & Clinical Research Centers, Centennial

80229

1st Allergy & Clinical Research Centers, Thornton

Sponsors
All Listed Sponsors
lead

1st Allergy & Clinical Research Center

OTHER